Print this page    •   Back to Web version of article

Medical News
FDA Probes Risks of HIV, Prostate, Other Drugs

May 4, 2010

The Food and Drug Administration's latest Adverse Event Reporting System update indicates the agency is investigating potential safety issues associated with the HIV drug Kaletra and several other medications. FDA said it is tracking reports of liver toxicity in patients who received Kaletra to prevent HIV infection following exposure to the virus (post-exposure prophylaxis). FDA also is looking into reports of male breast cancer in patients taking the prostate drugs Avodart or Proscar, and in those taking the baldness product Propecia. The quarterly report covers the period October through December 2009. FDA emphasized that "the listing of a drug and a potential safety issue on this Web site does not mean that FDA is suggesting prescribers should not prescribe the drug or that patients taking the drug should stop taking the medication." For more information, click here.

Back to other news for May 2010

Excerpted from:
Reuters
05.03.2010; Lisa Richwine




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art56528.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.